Cite
HARVARD Citation
Komajda, M. et al. (2016). Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post‐hoc analysis of SHIFT. European journal of heart failure. pp. 1182-1189. [Online].